Overview of resistance to systemic therapy in patients with breast cancer.
By A. González-Angulo, F. Morales-Vásquez, G. Hortobagyi. Advances in Experimental Medicine and Biology, 2007
931 citations recorded by the source corpus.
Subfields: Genetics, Molecular Biology, Oncology
View Paper: https://www.semanticscholar.org/paper/18cc9c9f992fe10add91ae66545703842fa13377
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
In Oncology
Citations in the corpus
- A CXCL1 paracrine network links cancer chemoresistance and metastasis (2012, neutral): “Ultimately, pan-resistance occurs, which in association with the progression of metastatic spread, an almost universally linked process, is the cause of death (Gonzalez-Angulo et al., 2007).”
- Recent progress in tumor pH targeting nanotechnology. (2008, background): “Amongst various cancer therapies, chemotherapy is one of major treatment modalities along with debulking surgery [1-2].”